Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Adaptive multi-model ensembles for improved epidemic projections and decision support.

medRxiv : the preprint server for health sciences·2026

Same author

Local Influenza Forecasts Outperform State-Level Forecasts in the United States.

medRxiv : the preprint server for health sciences·2026

Same author

Assessing the Impact of Timing and Coverage of United States COVID-19 Vaccination Campaigns: A Multi-Model Approach.

medRxiv : the preprint server for health sciences·2026

Same author

Workplace Adversity Among Critical Care Nurses: Associations With Key Organisational Factors.

Nursing in critical care·2026

Same author

Corrigendum: Shaping the Future of Dentistry: How Digital VR-Haptic Thinkers Are Revolutionizing Education by Thinking Big for Better Future in Oral Care.

European journal of dentistry·2025

Same author

Estimated impact of 2022-2023 influenza vaccines on annual hospital burden in the United States.

Proceedings of the National Academy of Sciences of the United States of America·2025

Search research articles

Related Experiment Video

Updated: Dec 7, 2025

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

Published on: June 23, 2022

Selecting pharmacies for COVID-19 testing to ensure access.

Simon Risanger¹, Bismark Singh², David Morton³

¹Department of Industrial Economics and Technology Management, Norwegian University of Science and Technology, Trondheim, Norway.

Medrxiv : the Preprint Server for Health Sciences

|September 30, 2020

Summary

Widespread pharmacy access to COVID-19 testing could reach 94% of the US population. Strategic pharmacy selection can significantly improve testing accessibility, reaching millions more people.

More Related Videos

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Related Experiment Videos

Last Updated: Dec 7, 2025

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

Published on: June 23, 2022

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Area of Science:

Public Health
Health Services Research
Epidemiology

Background:

Rapid diagnostic testing for COVID-19 is crucial for public health interventions like social distancing and contact tracing.
Current access to COVID-19 testing remains inadequate in many US communities.
Pharmacies present an underutilized resource with the potential to expand testing coverage.

Approach:

A facility location optimization model was employed, integrating willingness-to-travel data from the US National Household Travel Survey.
The model assessed the potential reach of COVID-19 testing if made available across all US pharmacies.
Analysis included comparing optimized pharmacy selection with random selection based on population density.

Key Points:

Expanding COVID-19 testing to all US pharmacies could make testing accessible to an estimated 94% of the population.
Independent pharmacies are vital for ensuring adequate testing coverage in less populated states.
Optimized selection of just 1,000 pharmacies can increase access by an estimated 29 million people compared to population-density-based selection.

Conclusions:

Leveraging pharmacies for COVID-19 testing can substantially improve access nationwide.
Judicious selection of testing sites, even with limited numbers, can enhance logistical efficiency and broaden reach.
Pharmacy-based testing is a scalable solution to enhance public health preparedness for infectious diseases.